These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2613854)

  • 21. [Serology of HIV infection].
    Gschnait F; Schwarz T; Hobisch G; Schmidt BL
    Hautarzt; 1989 Dec; 40(12):745-51. PubMed ID: 2695498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinopathy as the initial presentation of human immunodeficiency virus 2 infection.
    Handwerger BA; Urban AW; Gottlieb JL
    Arch Ophthalmol; 2000 Dec; 118(12):1695-6. PubMed ID: 11115268
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid tests for HIV type discrimination in West Africa may perform differently.
    Hønge BL; Jespersen S; Olesen JS; Erikstrup C; Wejse C
    J Int AIDS Soc; 2015; 18(1):19460. PubMed ID: 25609215
    [No Abstract]   [Full Text] [Related]  

  • 24. Retesting of sera for antibodies to HIV-1/HIV-2.
    Commun Dis Rep CDR Wkly; 1996 May; 6(18):153. PubMed ID: 8935418
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute fatal HIV encephalitis with negative serologic assays for antibody and antigen: diagnosis by polymerase chain reaction.
    Varma VA; Hunter S; Tickman R; Srinivasan A; Swan D
    N Engl J Med; 1989 Jun; 320(22):1494-5. PubMed ID: 2716802
    [No Abstract]   [Full Text] [Related]  

  • 26. Response to "Rapid tests for HIV type discrimination in West Africa may perform differently".
    Tchounga BK; Ekouevi DK; Eholie SP
    J Int AIDS Soc; 2015; 18(1):19380. PubMed ID: 25636349
    [No Abstract]   [Full Text] [Related]  

  • 27. Strategies for diagnosing HIV-1 infection in atypical Western blots.
    Chen MY; Lee KL; Hung CC; Chuang CY; Chou MJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):135-44. PubMed ID: 10592819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrimination of HIV-2 infection from HIV-1 infection by western blot and radioimmunoprecipitation analysis.
    Holzer TJ; Allen RG; Heynen CA; Kennedy MM; Knigge MF; Paul DA; Dawson GJ
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):515-24. PubMed ID: 2111161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-2 infection detected in Canada.
    Neumann PW; Lepine D; Woodside M; Levesque J; Frenette S; O'Shaughnessy MV; D'Souza I; Major C; Gregory B; Bond V
    Can Dis Wkly Rep; 1988 Jul; 14(28):125-6. PubMed ID: 3242886
    [No Abstract]   [Full Text] [Related]  

  • 30. Following up indeterminate HIV-1 western blots.
    Couroucé AM
    Lancet; 1989 Dec; 2(8675):1330-1. PubMed ID: 2574271
    [No Abstract]   [Full Text] [Related]  

  • 31. Application of a procedure starting with an HIV-I/HIV-2 mixed EIA.
    Chou MJ; Chen HL; Lin HC; Lin CC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Nov; 23(4):291-301. PubMed ID: 1983137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients.
    Loussert-Ajaka I; Ly TD; Chaix ML; Ingrand D; Saragosti S; Couroucé AM; Brun-Vézinet F; Simon F
    Lancet; 1994 Jun; 343(8910):1393-4. PubMed ID: 7910884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory diagnosis of HIV infection.
    Storch GA; Arens MQ
    Mo Med; 1989 Dec; 86(12):801-3. PubMed ID: 2622446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection.
    Närvänen A; Korkolainen M; Suni J; Korpela J; Kontio S; Partanen P; Vaheri A; Huhtala ML
    J Med Virol; 1988 Oct; 26(2):111-8. PubMed ID: 2460585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa.
    Brattegaard K; Kouadio J; Adom ML; Doorly R; George JR; De Cock KM
    AIDS; 1993 Jun; 7(6):883-5. PubMed ID: 8395857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of subjects with an indeterminate HIV-2 western blot.
    Pepin J; Dalby M; Gaye I; Berry N; Whittle H
    AIDS; 1991 Oct; 5(10):1274-5. PubMed ID: 1786162
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacterially produced HIV-2 env polypeptides specific for distinguishing HIV-2 from HIV-1 infections.
    Zuber M; Samuel KP; Lautenberger JA; Kanki PJ; Papas TS
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):525-34. PubMed ID: 2187502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIV antigen determination with the enzyme immunoassay].
    Stute R
    Beitr Infusionsther; 1988; 21():157-60. PubMed ID: 2462967
    [No Abstract]   [Full Text] [Related]  

  • 40. Avoiding indeterminate results in HIV-1 western blot using synthetic peptide assays. HIV-2 Spanish Study Group.
    Soriano V; Gutiérrez M; Tuset C; Martínez-Zapico R; Ortiz de Lejarazu R; González A; Aguilera A; Codina G; Ulloa F; Leal M
    Vox Sang; 1993; 64(4):250-1. PubMed ID: 8517053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.